Literature DB >> 29665276

Engineered Hsp Protein Nanocages for siRNA Delivery.

Xingang Guan1, Yu Chang1,2, Jinghui Sun2, Jianxi Song2, Yu Xie1.   

Abstract

The efficient delivery of small interfering RNA (siRNA) to tumor cells still remains a great challenge. Of the various nanocarriers, protein nanocages have attracted extensive interest due to their unique structure and suitable characteristics derived from their proteinaceous nature. However, most reported protein nanocages that are developed are based on virus capsid proteins, which may raise safety concerns, including those related to gene mutation and carcinogenesis. The development of nonviral protein-based systems for siRNA delivery is greatly needed. In this study, a novel siRNA delivery system based on heat shock protein (Hsp) nanocages is developed by a genetic engineering method. The delivery system could condense siRNA into stable complexes and protect the condensed siRNA from degradation. A cellular uptake analysis shows that siRNA is introduced into tumor cells mediated by Hsp-R9 nanocages. Green fluorescent protein (GFP) expression in HeLa-EGFP cells is significantly downregulated by Hsp-R9/siRNA complexes. The results indicate that Hsp nanocages may be a good platform for siRNA delivery into tumor cells.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  gene silencing; heat shock protein; protein nanocage; siRNA delivery

Mesh:

Substances:

Year:  2018        PMID: 29665276     DOI: 10.1002/mabi.201800013

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  6 in total

Review 1.  New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape.

Authors:  Maja van Hees; Sofie Slott; Anders Højgaard Hansen; Heon Seok Kim; Hanlee P Ji; Kira Astakhova
Journal:  Mol Ther       Date:  2021-06-04       Impact factor: 11.454

2.  Design and Synthesis of Piperazine-Based Compounds Conjugated to Humanized Ferritin as Delivery System of siRNA in Cancer Cells.

Authors:  Natalia Pediconi; Francesca Ghirga; Cristina Del Plato; Giovanna Peruzzi; Constantinos M Athanassopoulos; Mattia Mori; Maria Elisa Crestoni; Davide Corinti; Franco Ugozzoli; Chiara Massera; Alessandro Arcovito; Bruno Botta; Alberto Boffi; Deborah Quaglio; Paola Baiocco
Journal:  Bioconjug Chem       Date:  2021-05-12       Impact factor: 4.774

Review 3.  Protein-based vehicles for biomimetic RNAi delivery.

Authors:  Alex Eli Pottash; Christopher Kuffner; Madeleine Noonan-Shueh; Steven M Jay
Journal:  J Biol Eng       Date:  2019-02-26       Impact factor: 4.355

Review 4.  Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification.

Authors:  Jacob W Shreffler; Jessica E Pullan; Kaitlin M Dailey; Sanku Mallik; Amanda E Brooks
Journal:  Int J Mol Sci       Date:  2019-11-30       Impact factor: 5.923

5.  Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy.

Authors:  Masoud Delfi; Rossella Sartorius; Milad Ashrafizadeh; Esmaeel Sharifi; Yapei Zhang; Piergiuseppe De Berardinis; Ali Zarrabi; Rajender S Varma; Franklin R Tay; Bryan Ronain Smith; Pooyan Makvandi
Journal:  Nano Today       Date:  2021-03-11       Impact factor: 18.962

Review 6.  Developing Protein-Based Nanoparticles as Versatile Delivery Systems for Cancer Therapy and Imaging.

Authors:  Febrina Sandra; Nisar Ul Khaliq; Anwar Sunna; Andrew Care
Journal:  Nanomaterials (Basel)       Date:  2019-09-16       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.